StockSelector.com
  Research, Select, & Monitor Thursday, November 21, 2019 1:06:39 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Dynavax Technologies Corp.$5.22($.68)(11.53%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Dynavax Technologies Corp. vs Biotechnology

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.




An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: $8.2 Mil $96,519.1 Mil
  Market Cap: $392.1 Mil $514,139.0 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 2,384.8% 85.8%
  Estimated Revenue: 340.9% 38.4%
  Historic Earnings: N/A (9.1%)
  Estimated Earnings: N/A 12.3%
  Stock Price (1 Year): (54.8%) 23.3%
  Cash per Share: 79.5% 10.8%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: N/A 50.9
  Price-to-Sales: 13.1 N/A
  Price-to-Book: 5.2 5.1
  Dividend Yield: N/A N/A
  Market Cap: $392.1 Mil $12,540.0 Mil
  Operations
  Net Margin: (519.9%) (251.5%)
  Gross Margin: (33.4%) 73.2%
  Return on Equity: (2.5) (.6)
  Return on Assets: (.8) (.2)
  Balance Sheet
  Current Ratio: 4.6 6.4
  Quick Ratio: 4.1 6.0
  Cash Ratio: 3.8 4.9
  Debt-to-Equity: 2.3 1.3
  Interest Coverage: .4 1.1
 Technicals
  Relative-Strength Index: 56.4 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $225.51 $135,757.0 Mil
  Gilead Sciences, Inc.  (GILD) $64.88 $82,203.0 Mil
  Celgene Corp.  (CELG) $108.24 $78,961.1 Mil
  Biogen Inc.  (BIIB) $285.40 $52,570.7 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $344.24 $39,312.2 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.